Celldex Therapeutics Inc
F:TCE2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Celldex Therapeutics Inc
F:TCE2
|
US |
|
H
|
Hess Corp
XMUN:AHC
|
US |
|
Geberit AG
F:GBRA
|
CH |
|
C
|
China Mobile Ltd
XHAM:CTM
|
CN |
|
Q
|
Quanta Services Inc
DUS:QAA
|
US |
|
B
|
Barrick Gold Corp
DUS:ABR
|
CA |
|
I
|
Industrial and Commercial Bank of China Ltd
XMUN:ICK
|
CN |
|
R
|
Relx PLC
XMUN:RDED
|
UK |
|
N
|
News Corp
F:NC0
|
US |
|
I
|
Intuitive Surgical Inc
SWB:IUI1
|
US |
|
Solocal Group SE
F:QS30
|
FR |
|
F
|
Fujikura Ltd
DUS:FJK
|
JP |
|
E
|
Emira Property Fund
JSE:EMI
|
ZA |
|
China Shenhua Energy Co Ltd
F:IKF
|
CN |
|
H
|
Hays PLC
F:HAY
|
UK |
|
CGI Inc
F:CJ5A
|
CA |
|
Camtek Ltd
F:CMZ
|
IL |
|
G
|
Globant SA
F:2G2
|
LU |
|
M
|
Mitsubishi UFJ Financial Group Inc
SWB:MFZA
|
JP |
|
S
|
Siam Global House PCL
SET:GLOBAL
|
TH |
|
C
|
CNOOC Ltd
SSE:600938
|
CN |
|
D
|
Dominion Energy Inc
XMUN:DOD
|
US |
|
A
|
Advantest Corp
XBER:VAN
|
JP |
|
B
|
Banco Bilbao Vizcaya Argentaria SA
XBER:BOY
|
ES |
Bankruptcy Probability
Celldex Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Celldex Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Celldex Therapeutics Inc
NASDAQ:CLDX
|
2.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
356.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
179.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
163B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
109.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
75.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
41.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
57.8B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Celldex Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Celldex Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
